Rein Therapeutics Inc (NASDAQ: RNTX) kicked off on Tuesday, up 21.01% from the previous trading day, before settling in for the closing price of $1.19. Over the past 52 weeks, RNTX has traded in a range of $1.04-$4.40.
Annual sales at Healthcare sector company grew by 31.90% over the past five years. While this was happening, its average annual earnings per share was recorded 72.51%. With a float of $21.66 million, this company’s outstanding shares have now reached $23.05 million.
Rein Therapeutics Inc (RNTX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rein Therapeutics Inc is 8.02%, while institutional ownership is 26.23%. The most recent insider transaction that took place on Dec 05 ’24, was worth 898. In this transaction President and CEO of this company bought 400 shares at a rate of $2.24, taking the stock ownership to the 239 shares.
Rein Therapeutics Inc (RNTX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.27 earnings per share (EPS), higher than consensus estimate (set at -0.45) by 0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.86% during the next five years compared to 31.90% growth over the previous five years of trading.
Rein Therapeutics Inc (NASDAQ: RNTX) Trading Performance Indicators
Take a look at Rein Therapeutics Inc’s (RNTX) current performance indicators. Last quarter, stock had a quick ratio of 0.86. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.69, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Rein Therapeutics Inc (RNTX)
Rein Therapeutics Inc (NASDAQ: RNTX) saw its 5-day average volume 0.17 million, a positive change from its year-to-date volume of 77785.0. As of the previous 9 days, the stock’s Stochastic %D was 51.26%.
During the past 100 days, Rein Therapeutics Inc’s (RNTX) raw stochastic average was set at 29.41%, which indicates a significant decrease from 71.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1052 in the past 14 days, which was lower than the 0.1310 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1919, while its 200-day Moving Average is $1.7174. Nevertheless, the first resistance level for the watch stands at $1.6100 in the near term. At $1.7800, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9900. If the price goes on to break the first support level at $1.2300, it is likely to go to the next support level at $1.0200. Assuming the price breaks the second support level, the third support level stands at $0.8500.
Rein Therapeutics Inc (NASDAQ: RNTX) Key Stats
The company with the Market Capitalisation of 33.91 million has total of 23,305K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -62,880 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,820 K.
